Literature DB >> 7509323

Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody.

M J Losman1, K E Novick, D M Goldenberg, M Monestier.   

Abstract

Anti-idiotype antibodies (Ab2) that immunologically mimic tumor antigens are auspicious agents for the active immunization of cancer patients. We have developed W12, a rat monoclonal IgG1 Ab2 to MN-14, a murine anti-carcinoembryonic antigen (CEA) monoclonal antibody. W12 is specific for MN-14 and does not react with other isotype-matched anti-CEA monoclonal antibodies. Moreover, W12 inhibits the binding between MN-14 and CEA. Anti-CEA antibodies can be induced by immunization with W12 (but not with control rat IgG) in xenogenic animals (mice or rabbits). Immunoblotting studies indicate that the internal image determinant borne by W12 is conformational and requires the association of the heavy and light chains of the Ab2 molecule. This study indicates that W12 is a potential idiotype vaccine in patients with CEA-producing cancers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509323     DOI: 10.1002/ijc.2910560419

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting.

Authors:  Edmund A Rossi; David M Goldenberg; Thomas M Cardillo; William J McBride; Robert M Sharkey; Chien-Hsing Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.

Authors:  K A Foon; M Chakraborty; W J John; A Sherratt; H Köhler; M Bhattacharya-Chatterjee
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

3.  Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response.

Authors:  Jie Ma; Liqiang Zhou; Daqing Wang
Journal:  Jpn J Cancer Res       Date:  2002-01

4.  Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results.

Authors:  R Schoffelen; O C Boerman; D M Goldenberg; R M Sharkey; C M L van Herpen; G M Franssen; W J McBride; C-H Chang; E A Rossi; W T A van der Graaf; W J G Oyen
Journal:  Br J Cancer       Date:  2013-07-16       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.